top of page

Recursion's Chris Gibson on the potential utility of machine learning and AI in drug development

Chris Gibson describes the new technologies that are accelerating and refining drug development, shares best practices, and elaborates on Recursion's partnerships.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page